Article Information
History
- October 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Yong Dam Jeong1,2,†,
- Keisuke Ejima3,†,*,
- Kwang Su Kim1,†,
- Shoya Iwanami1,
- Shingo Iwami1,4,5,6,7,* and
- Kazuyuki Aihara8
- 1interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan
- 2Department of Mathematics, Pusan National University, Busan, South Korea
- 3Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, IN, USA
- 4Institute of Mathematics for Industry, Kyushu University, Fukuoka, Japan
- 5Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan
- 6NEXT-Ganken Program, Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan
- 7Science Groove Inc., Fukuoka, Japan
- 8International Research Center for Neurointelligence, The University of Tokyo, Tokyo, Japan
- ↵*Corresponding authors: kejima{at}iu.edu (KE) iwami.iblab{at}bio.nagoya-u.ac.jp (S Iwami)
↵† These authors contributed equally to this work.
Posted October 11, 2021.
Safely return to schools and offices: early and frequent screening with high sensitivity antigen tests effectively identifies COVID-19 patients
